This year the Nobel Prize Committee has awarded the Physiology or Medicine prize to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. This week we're highlighting four other discoveries over the past 100 years that have changed the...
Antibiotic resistance has always been a global public health problem. While many of my colleagues carry out research aimed at discovering new antibiotics, my job is to help all of us get better at looking after the antibiotics we already have.
In a week that sees the MHRA and CRUK publish critical information about the UK’s clinical research environment post-Brexit, ABPI's Deputy Chief Scientific Officer Dr Sheuli Porkess explores what it means for the pharmaceutical industry.
Pharmaceutical companies continue to plan for the UK’s exit from the EU. As they do, the terms on which the UK will leave - and the terms of the future relationship – remain uncertain.
As Britain Brexits from the EU, it’s going to be more important than ever that the UK convincingly demonstrates to the world that it embraces new innovations.
With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.
Erik Nordkamp, Managing Director of Pfizer UK explains why Pfizer has partnered with the Science Museum to sponsor its new exhibition on antibiotic resistance.
Patients, partnerships and pioneering science are at the heart of developing advanced therapies in the next wave of innovation to provide transformative treatments and cures, according to latest developments reported at the Better Science, Better Health: Advanced Therapies – Opportunities and...
The Declaration on Combating Antimicrobial Resistance (AMR) represents a major milestone in the global response to the rising threat of drug resistance with commercial drug and diagnostic developers for the first time agreeing on a common set of principles. One year on, the IFMPA sets out 7 key...
It can take about 12 years and over £1 billion pounds to bring a medicine to the market. So with all this time, money and effort you might think that everything would be known about a medicine when it is launched on the market. But is this really the case?